FAST & RELIABLE HEALTH TEST AT HOME
HOW IT WORKS
The class-II medical device provides responses within 10 seconds.
Facon Biomed uses its proprietary microsphere immunoassay and optical detection method for accurate signal detection.
The handheld device is wirelessly connected to the cell phone for model fitting and data display. The whole process is easy to use.
Facon Biomed develops novel Class-2 biosensors and test strips for trace antibody/hormone detection in OTC based or home based healthcare products. The biomedical device uses time resolved fluorescent immunoassay (TRFIA) on women’s reproduction biomarkers like LH, PdG, AMH to provide accurate prediction and confirmation of ovulation for conception.
Facon Biomed realizes that with the onset of nanotechnology and microsphere integration into the biomedical devices, it enables early detection of disease, hormone cycles in the human biological process. We participate in the biomedical sensor market. The biosensors market is valued at USD 25.5 billion in 2021 and is projected to reach USD 36.7 billion by 2026; it is expected to grow at a CAGR of 7.5% from 2021 to 2026.
Our objective is to use the advantage of TRFIA to separate the excitation from the emission temporally so that the detection sensitivity can be greatly improved. Another objective is to eliminate the any moving parts in the device to provide a repeatable and consistent results. By achieving these two objectives, the novel class-2 medical device is highly integrated, reliable and miniaturized.